Banque Cantonale Vaudoise’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,042
Closed -$23K 1056
2023
Q4
$23K Sell
1,042
-247
-19% -$5.45K ﹤0.01% 879
2023
Q3
$27K Sell
1,289
-33
-2% -$691 ﹤0.01% 1030
2023
Q2
$62K Hold
1,322
﹤0.01% 941
2023
Q1
$55K Hold
1,322
﹤0.01% 940
2022
Q4
$50K Hold
1,322
﹤0.01% 951
2022
Q3
$52K Sell
1,322
-27
-2% -$1.06K ﹤0.01% 978
2022
Q2
$44K Sell
1,349
-720
-35% -$23.5K ﹤0.01% 1018
2022
Q1
$68K Sell
2,069
-2,439
-54% -$80.2K ﹤0.01% 971
2021
Q4
$192K Sell
4,508
-275
-6% -$11.7K 0.01% 836
2021
Q3
$212K Buy
4,783
+272
+6% +$12.1K 0.01% 782
2021
Q2
$256K Buy
4,511
+429
+11% +$24.3K 0.01% 782
2021
Q1
$306K Sell
4,082
-81
-2% -$6.07K 0.02% 667
2020
Q4
$360K Sell
4,163
-3,591
-46% -$311K 0.02% 577
2020
Q3
$474K Buy
7,754
+450
+6% +$27.5K 0.03% 443
2020
Q2
$304K Sell
7,304
-137
-2% -$5.7K 0.02% 539
2020
Q1
$214K Buy
7,441
+4,618
+164% +$133K 0.02% 604
2019
Q4
$204K Buy
+2,823
New +$204K 0.01% 718